|
28.05.25 - 13:13
|
ADDvise announces that the conditions for early redemption of outstanding secured bonds have been fulfilled (Cision)
|
|
ADDvise Group AB (publ) (“ADDvise” or the “Company”) announced on 14 May 2025 that ADDvise intends to redeem the Company's outstanding senior secured bonds with ISIN SE0020180271 and ISIN NO0013180786 (the “Early Redemption”).
The Early Redemption was conditional upon the entering into of the new secured facilities agreement of the equivalence of SEK 450 million with Nordea Bank Abp, filial i Sverige (the “New Facilities Agreement”), as well as on the Company receiving the proceeds from the issue of its new senior unsecured bonds of SEK 800 million (the “Bond Issue”), as communicated by...
|
|
26.05.25 - 16:12
|
ADDvise enters into facilities agreement with Nordea – reduces financial costs by approximately SEK 56 million per year (Cision)
|
|
ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will on 28 May 2025 also issue new senior unsecured bonds of SEK 800 million with a floating interest rate of 3 months STIBOR plus 3.50 per cent. per annum. As previously communicated, the company intends to use the net proceeds from the bond issue as well as part of loan under the facilities agreement to refinance the company's outstanding senior secured bonds in SEK and USD.
With the support of...
|
|
20.05.25 - 13:12
|
ADDvise announces the result of the tender offer regarding its outstanding senior secured bonds (Cision)
|
|
On 14 May 2025, ADDvise Group AB (publ) (“ADDvise” or the “Company”) announced a tender offer (the “Tender Offer”) to the holders of the Company's outstanding senior secured bonds of SEK 1,450 million due 2026 with ISIN SE0020180271 and senior secured bonds of USD 60 million due 2027 with ISIN NO0013180786 (the “2026 Bonds”, the “2027 Bonds” and together the “Outstanding Bonds”). Pursuant to the Tender Offer, the Company offered to repurchase Outstanding Bonds for cash at a purchase price equal to 102.278 per cent. of the nominal amount for the 2026 Bonds and 105.182 per cent. of the...
|
|
19.05.25 - 14:54
|
ADDvise issues new SEK senior unsecured bonds (Cision)
|
|
ADDvise Group AB (publ) (“ADDvise” or the “Company”) has today successfully placed senior unsecured bonds of SEK 800 million under a framework of SEK 1,600 million and with a tenor of 3.5 years (the “New Bonds” or the “Bond Issue”). The New Bonds will carry floating interest of STIBOR 3m plus 3.50 per cent. per annum and will be issued at par. The settlement date for the Bond Issue is expected to be 28 May 2025. The Bond Issue saw strong demand from a broad base of Nordic and international institutional investors.
“We are very pleased with the outcome, which contributes to an efficient...
|
|
|
12.05.25 - 13:54
|
Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs (Cision)
|
|
Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for the organization. The CEO has therefore decided to appoint Johan as ADDvise permanent CFO.
Staffan Torstensson will, in addition to his role as CEO, take on the position of Head of Healthcare. With his strong financial background, Staffan brings a results-oriented leadership that will complement the strong operational expertise already present in the organization. He will work closely with a...
|
|
12.05.25 - 11:30
|
Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 (Cision)
|
|
ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved on, among other things, re-election of Fredrik Celsing as board member and chair, re-election of Johanne Louise Brændgaard, Thomas Eklund, Rikard Akhtarzand and Anna Ljung as board members, re-election of Öhrlings PricewaterhouseCoopers AB as the auditor of the company, and approval of the remuneration report 2024.
Adoption of income statements and balance sheets
The annual...
|
|
03.05.25 - 13:30
|
Invitation to presentation of interim report January 1 – March 31, 2025 (Cision)
|
|
ADDvise Group publishes its interim report January 1 – March 31, 2025 on Friday, May 9, 2025 at 7.45 am (CET).
Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report.
Webcast
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
https://addvise-group.events.inderes.com/q1-report-2025/register
Conference call
If you wish to participate via teleconference,...
|
|
09.04.25 - 09:54
|
Notice to the annual general meeting of ADDvise Group AB (publ) (Cision)
|
|
ADDvise Group AB (publ), reg. no. 556363–2115, hereby convenes the annual general meeting on 12 May 2025 at 10:00 CEST at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09.30 CEST.
NOTIFICATION
Shareholders wishing to attend the annual general meeting must:
i) be registered in the share register kept by Euroclear Sweden AB on the record date 2 May 2025, or, if the shareholder has had his/her shares registered in the name of a nominee, request that the nominee registers the shares for voting purposes in such time that the registration is...
|
|
08.04.25 - 19:54
|
ADDvise raises approximately SEK 457 million in the rights issue (Cision)
|
|
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES), AUSTRALIA, CANADA, BELARUS, HONG KONG, JAPAN, NEW ZEALAND AND RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, REQUIRE REGISTRATION OR ANY OTHER MEASURE UNDER APPLICABLE LAW. OTHER RESTRICTIONS APPLY. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.
On 7 April 2025, ADDvise Group AB (publ) (“ADDvise” or the “Company”...
|
|
08.04.25 - 08:37
|
ADDvise Group publishes annual report and sustainability report for 2024 (Cision)
|
|
Today, ADDvise Group AB (publ) is publishing the annual report and the sustainability report for 2024. Both reports are available on ADDvise's website: www.addvisegroup.com.
The annual report and the sustainability report are published in Swedish and English. The Swedish versions represent the originals.
For further information, please contact:
Staffan Torstensson, CEO
+46 (0)70-433 20 19
staffan.orstensson@addvisegroup.se
Johan Irwe, Interim CFO
+46 (0)73-731 26 11
johan.irwe@addvisegroup.se
About ADDvise
ADDvise is an international...
|
|
07.04.25 - 19:54
|
ADDvise announces preliminary outcome of the rights issue (Cision)
|
|
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES), AUSTRALIA, CANADA, BELARUS, HONG KONG, JAPAN, NEW ZEALAND AND RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, REQUIRE REGISTRATION OR ANY OTHER MEASURE UNDER APPLICABLE LAW. OTHER RESTRICTIONS APPLY. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.
ADDvise Group AB (publ) (“ADDvise” or the “Company”) announces the...
|
|
20.03.25 - 11:54
|
ADDvise publishes prospectus in connection with a rights issue (Cision)
|
|
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES), AUSTRALIA, CANADA, BELARUS, HONG KONG, JAPAN, NEW ZEALAND AND RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, REQUIRE REGISTRATION OR ANY OTHER MEASURE UNDER APPLICABLE LAW. OTHER RESTRICTIONS APPLY. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.
On 7 February 2025, ADDvise Group AB (publ) ("ADDvise" or the "...
|
|
|
17.03.25 - 23:42
|
XFRA : CAPITAL ADJUSTMENT INFORMATION - 19.03.2025 - SE0007464862 (XETRA)
|
|
Das Instrument Q3I SE0007464862 ADDVISE GROUP AB B EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025
The instrument Q3I SE0007464862 ADDVISE GROUP AB B EQUITY is traded cum capital adjustment on 18.03.2025 and ex capital adjustment on 19.03.2025...
|
|
12.03.25 - 11:30
|
Report from the extra ordinary general meeting in ADDvise Group AB (publ) (Cision)
|
|
ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve the board's resolution regarding a rights issue of shares of series A and series B, approve the board's resolution on a directed issue of warrants and to authorise the board to issue shares of series B as compensation to guarantors in the rights issue.
Amendment of the articles of association
The general meeting resolved, in accordance with the board's proposal, to amend §4 and §5 of the...
|
|
19.12.24 - 08:01
|
ADDvise receives order worth EUR 2.6 million (Cision)
|
|
ADDvise Group's subsidiary MRC Systems has received an order from Rafarm, a leading pharmaceutical company based in Greece.
The order is worth approximately EUR 2.6 million. The order involves design, paneling, and installation of a cleanroom and associated accessories. Delivery of the order is scheduled to be completed during Q4 2025.
For further information, please contact:
Staffan Torstensson, CEO
+46 704 33 20 19
staffan.torstensson@addvisegroup.se
Important information
This information is information that ADDvise Group AB is required to disclose under the EU Market...
|
|
06.12.24 - 14:25
|
ADDvise receives allocation decision worth approximately SEK 72 million (Cision)
|
|
ADDvise Group's subsidiary Hettich Labinstrument AB has received an allocation decision from Region Stockholm worth approximately SEK 72 million. The allocation decision involves the delivery of blood specimen collection equipment over a four-year period, commencing in May 2025.
The allocation decision can be appealed up until December 20, 2024.
For further information, please contact:
Staffan Torstensson, CEO
+46 704 33 20 19
staffan.torstensson@addvisegroup.se
Important information
This information is information that ADDvise Group AB is required to disclose under the EU...
|
|
11.11.24 - 13:01
|
ADDvise explores potential divestment of its subsidiary Germa (Cision)
|
|
ADDvise is exploring the possibility of divesting its subsidiary AB Germa. Germa has shifted its focus primarily towards defense equipment, which falls outside of ADDvise's core business within life science. ADDvise is therefore evaluating options to find a new owner who can further develop Germa and maximize its full potential within the defense segment.
Since ADDvise acquired the company in 2017, Germa has experienced strong growth. At the time of acquisition, Germa had revenues of SEK 30 million with an EBITDA of SEK 3.5 million. As of the rolling twelve-month period ending September...
|
|
11.11.24 - 11:25
|
ADDvise receives order worth USD 1.8 million (Cision)
|
|
ADDvise Group's subsidiary MRC Systems has received an order from Orbitworks, a company specialized in advanced technology, based in United Arab Emirates.
The order is worth approximately USD 1.8 million. The order involves design, paneling, and installation of a cleanroom and associated accessories. Delivery of the order is scheduled to be completed during Q2 2025.
For further information, please contact:
Staffan Torstensson, CEO
+46 704 33 20 19
staffan.torstensson@addvisegroup.se
Important information
This information is information that ADDvise Group AB is required to...
|
|